(VIANEWS) – ALTAREA (ALTA.PA), SANOFI (SAN.PA), TELEPERFORMANCE (TEP.PA) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| ALTAREA (ALTA.PA) | 7.65% | 2023-07-05 07:36:42 |
| SANOFI (SAN.PA) | 3.6% | 2023-07-05 07:02:48 |
| TELEPERFORMANCE (TEP.PA) | 2.54% | 2023-07-05 07:04:20 |
| VIOHALCO (VIO.BR) | 2.05% | 2023-07-05 07:17:22 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. ALTAREA (ALTA.PA)
7.65% Foward Dividend Yield
ALTAREA’s last close was €103.80, 34.39% below its 52-week high of €158.20. Intraday change was -0.77%.
Altarea is the French leader in low-carbon urban transformation, with the most comprehensive real estate offering to serve the city and its users. In each of its activities, the Group has all the expertise and recognised brands needed to design, develop, market and manage tailor-made real estate products. Altarea is listed in compartment A of Euronext Paris.
Earnings Per Share
As for profitability, ALTAREA has a trailing twelve months EPS of €15.58.
PE Ratio
ALTAREA has a trailing twelve months price to earnings ratio of 6.61. Meaning, the purchaser of the share is investing €6.61 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.37%.
Sales Growth
ALTAREA’s sales growth for the current quarter is negative 21.5%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 30, 2022, the estimated forward annual dividend rate is 9.75 and the estimated forward annual dividend yield is 7.65%.
More news about ALTAREA.
2. SANOFI (SAN.PA)
3.6% Foward Dividend Yield
SANOFI’s last close was €97.73, 7.08% below its 52-week high of €105.18. Intraday change was 0.16%.
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €6.65.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 14.72. Meaning, the purchaser of the share is investing €14.72 for every euro of annual earnings.
Sales Growth
SANOFI’s sales growth is 2.7% for the present quarter and 0.3% for the next.
Yearly Top and Bottom Value
SANOFI’s stock is valued at €97.89 at 17:50 EST, below its 52-week high of €105.18 and way higher than its 52-week low of €76.45.
More news about SANOFI.
3. TELEPERFORMANCE (TEP.PA)
2.54% Foward Dividend Yield
TELEPERFORMANCE’s last close was €155.30, 53.59% under its 52-week high of €334.60. Intraday change was -0.13%.
Teleperformance SE, together with its subsidiaries, engages in the provision of outsourced customer and citizen experience management, and related services in France and internationally. The company operates in two segments, Core Services and Digital Integrated Business Services, and Specialized Services. The Core Services and Digital Integrated Business Services segment offers customer and citizen care; customer relationship operations; technical support; and technical assistance and customer acquisition services, as well as back-office solutions and integrated services, including social media content moderation services and data labeling for automation solutions; and knowledge services in the field of analytics solutions, automated systems, and artificial intelligence. The company also manages business processes, as well as provides digital platform, consulting, and data analysis services; and business process outsourcing services for government agencies. The Specialized Services segment provides on-line interpretation, visa application management, health management services, and accounts receivable credit management services. It also offers digital recruitment process outsourcing; consumer health management business services and related digital solutions integration; translation and interpreting services; and business process outsourcing services for government agencies in the United States. The company serves automotive, energy and utilities, insurance, public sector, technology, travel and hospitality, and banking and financial services, as well as healthcare, media, retail and e-commerce, crypto, cargo, telecom, and video games industries. Teleperformance SE was incorporated in 1989 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, TELEPERFORMANCE has a trailing twelve months EPS of €10.9.
PE Ratio
TELEPERFORMANCE has a trailing twelve months price to earnings ratio of 14.23. Meaning, the purchaser of the share is investing €14.23 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.89%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TELEPERFORMANCE’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
TELEPERFORMANCE’s stock is valued at €155.10 at 17:50 EST, way under its 52-week high of €334.60 and way higher than its 52-week low of €137.30.
Moving Average
TELEPERFORMANCE’s worth is below its 50-day moving average of €165.88 and way under its 200-day moving average of €223.32.
More news about TELEPERFORMANCE.
4. VIOHALCO (VIO.BR)
2.05% Foward Dividend Yield
VIOHALCO’s last close was €5.92, 5.73% below its 52-week high of €6.28. Intraday change was 1.86%.
Viohalco S.A., through its subsidiaries, manufactures, and sells aluminium, copper, cables, and steel and steel pipe products worldwide. The company operates through seven segments: Aluminium, Cables, Copper, Steel, Steel Pipes, Real Estate, Other Activities. The Aluminium segment offers aluminium products, including coils, strips, sheets, and foils for various applications; and rolled and extruded products for construction, rigid and flexible packaging, transportation, household, industrial, architectural systems, and automotive applications, as well as lithographic coils. The Cables segment manufactures power and telecommunication cables, as well as enamelled wires and plastic and rubber compounds. The Copper segment provides copper tubes; copper and brass strips, sheets, discs and plates, and special copper alloy strips; copper bus bars and rods, brass rods and tubes, profiles and wires, copper alloy wire, and net; and cables and conductors, enamelled wires, and copper and aluminium wire rods, as well as plastic and rubber compounds. The Steel segment offers long, flat, and downstream steel products. The Steel Pipes segment provides steel pipes for the oil, gas, CO2, water transportation, and oil and gas extraction, as well as hollow structural sections for construction application. The Real Estate segment develops and manages large-scale commercial and industrial properties. The Other Activities segment produces products and solutions for the optimization of industrial and business processes. The company serves clients in building and construction, packaging, transportation, energy and power networks, heating, ventilation, air conditioning and refrigeration, water supply, telecommunications, printing, and other industrial sectors. Viohalco S.A. was incorporated in 1937 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, VIOHALCO has a trailing twelve months EPS of €1.04.
PE Ratio
VIOHALCO has a trailing twelve months price to earnings ratio of 5.8. Meaning, the purchaser of the share is investing €5.8 for every euro of annual earnings.
More news about VIOHALCO.
